Milan (Italy) and Dortmund (Germany) – July 8th, 2020 – IMAX Discovery GmbH, a leading research driven biotechnology company with expertise in the identification of novel, natural active ingredients, and Naicons Srl, a biotechnology company specialized in microbial products for drug discovery, announce today that they have entered into a strategic collaboration to provide integrated services for the identification and development of bioactive compounds from microbial origin for a variety of applications, including flavor & fragrance, cosmetics, agrichem, animal health and pharma. This partnership will create one of the largest worldwide collections of natural products from microbial origin. IMAX Discovery will provide functional assays and perform compound profiling and screening activities. Naicons will provide compound isolation and purification activities. The combination of the two companies’ platforms ( Brochure MicrobialStrains_Naicons-IMAX_200708 ), each with a long-standing reputation and track record of scientific excellence and delivery for their partners, offers integrated solutions for the discovery, profiling, purification, characterization and scale-up of bioactive product candidates derived from microorganisms.
For more information about IMAX Discovery please contact Michela Stucchi by phone at +49 160 90890824 or by email firstname.lastname@example.org. For more information about Naicons please contact Margherita Sosio by phone at +39 02 56660142 or by email email@example.com.
About IMAX Discovery GmbH
IMAX Discovery is a research driven company located in Dortmund, Germany. The company creates new product innovation through the generation and development of novel natural ingredients for the food, beverage, perfume and cosmetic industries. IMAX Discovery offers integrated solutions tailored to the client’s and partner’s specific needs for the entire flavour, fragrance and cosmetic discovery process. Thanks to its strong know-how and expertise around taste and olfactory receptors and natural products, IMAX Discovery also generates proprietary product pipelines of natural product based on novel taste and fragrance modulators.
IMAX Discovery is a subsidiary of Axxam SpA in Milan, Italy.
For more information, please visit https://www.imaxdiscovery.com/.
About Naicons Srl
Naicons is a research driven biotechnology company located in Milan, Italy, devoted to discovering and developing novel bioactive compounds. Naicons assets comprise one of the largest and most diversified collection of actinomycete bacteria, a library with thousands of different microbial-fermentation extracts with associated metabolic fingerprints and databases for prioritizing compounds. These assets can be applied to a plethora of programs in the pharma, animal health and agrichem sectors to discover new drug leads. Naicons has the facilities and know-how to perform all activities required to produce, purify and characterize up to several grams of microbial products. Naicons internal discovery programs aim at identifying novel antibiotics against multidrug resistant bacterial pathogens.
For more info, please visit www.naicons.com
Download brochure: Brochure MicrobialStrains_Naicons-IMAX_200708